array(3) { ["company_details"]=> array(13) { ["name"]=> string(16) "COLORCON LIMITED" ["slug"]=> string(25) "1f2f0-gb-colorcon-limited" ["logo"]=> NULL ["description"]=> string(912) "Colorcon® is a world leader in the development, supply and technical support of formulated film coating systems, modified release technologies, and functional excipients for the pharmaceutical and nutritional industries. Our best-in-class products and technologies are complemented by our extensive formulation experience, application data and value-added services to support all phases of solid oral dose design, development and manufacture. Our focus on market issues and technology development has earned Colorcon an international reputation as a pharmaceutical supplier of choice. That reputation is based on superior product quality, unparalleled technical support, extensive regulatory assistance and reliable supply from multiple locations. Colorcon has 22 technical service laboratories globally and more than 1300 employees exclusively dedicated to its customer base. Follow us on Twitter @Colorcon" ["address_street"]=> string(14) "Flagship House" ["address_place"]=> string(8) "DARTFORD" ["address_region"]=> NULL ["founding_date"]=> NULL ["website_domain"]=> NULL ["website_url"]=> NULL ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(264) ["article_count"]=> int(96) } ["articles"]=> array(1) { [0]=> array(7) { ["title_en"]=> string(35) "Mother wins breach of contract case" ["snippet_en"]=> string(181) "A mother whose ex-boss said all women of child-bearing age should be sterilised won her claim for breach of contract. But Gwen Bryne's claim for sexual discrimination was thrown out" ["url"]=> string(85) "https://www.dailymail.co.uk/news/article-104038/Mother-wins-breach-contract-case.html" ["image_url"]=> NULL ["source"]=> string(15) "dailymail.co.uk" ["publication_date"]=> string(10) "2002-03-08" ["categories"]=> array(6) { [0]=> string(7) "Layoffs" [1]=> string(10) "Cybercrime" [2]=> string(17) "Business Disputes" [3]=> string(20) "Contract negotiation" [4]=> string(5) "Legal" [5]=> string(15) "Deals & Tenders" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(14) } [1]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(11) } [2]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(9) } [3]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(8) } [4]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(4) } [5]=> array(2) { ["name"]=> string(37) "Product Design & Lifecycle Management" ["count"]=> int(4) } [6]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(3) } [7]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(2) } [8]=> array(2) { ["name"]=> string(15) "Blogs & Columns" ["count"]=> int(2) } [9]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(2) } [10]=> array(2) { ["name"]=> string(22) "EU Political Evolution" ["count"]=> int(2) } [11]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(2) } [12]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(1) } [13]=> array(2) { ["name"]=> string(20) "Contract negotiation" ["count"]=> int(1) } [14]=> array(2) { ["name"]=> string(10) "Cybercrime" ["count"]=> int(1) } [15]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(1) } [16]=> array(2) { ["name"]=> string(41) "E-commerce and Technological Developments" ["count"]=> int(1) } [17]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(1) } [18]=> array(2) { ["name"]=> string(23) "Supply Chain Management" ["count"]=> int(1) } [19]=> array(2) { ["name"]=> string(15) "Supply & Demand" ["count"]=> int(1) } [20]=> array(2) { ["name"]=> string(17) "Business Disputes" ["count"]=> int(1) } [21]=> array(2) { ["name"]=> string(19) "Foreign Development" ["count"]=> int(1) } [22]=> array(2) { ["name"]=> string(7) "Funding" ["count"]=> int(1) } [23]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(1) } [24]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(1) } [25]=> array(2) { ["name"]=> string(22) "Business Certification" ["count"]=> int(1) } [26]=> array(2) { ["name"]=> string(33) "Materials Sourcing and Efficiency" ["count"]=> int(1) } [27]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(1) } [28]=> array(2) { ["name"]=> string(10) "New Market" ["count"]=> int(1) } [29]=> array(2) { ["name"]=> string(7) "Opening" ["count"]=> int(1) } } } 1f2f0-gb-colorcon-limited

COLORCON LIMITED

Location

Founded

Website

Articles

96 Articles

Category

Pharmaceutical Preparations

Description

Colorcon® is a world leader in the development, supply and technical support of formulated film coating systems, modified release technologies, and functional excipients for the pharmaceutical and nutritional industries. Our best-in-class products and technologies are complemented by our extensive formulation experience, application data and value-added services to support all phases of solid oral dose design, development and manufacture. Our focus on market issues and technology development has earned Colorcon an international reputation as a pharmaceutical supplier of choice. That reputation is based on superior product quality, unparalleled technical support, extensive regulatory assistance and reliable supply from multiple locations. Colorcon has 22 technical service laboratories globally and more than 1300 employees exclusively dedicated to its customer base. Follow us on Twitter @Colorcon

Articles

Mother wins breach of contract case

2002-03-08 (dailymail.co.uk)

Mother wins breach of contract case

A mother whose ex-boss said all women of child-bearing age should be sterilised won her claim for breach of contract. But Gwen Bryne's claim for sexual discrimination was thrown out

Read more

Newsletter subscription